I thoroughly recommend Elizabeth as an innovative drug developer.  I first met Elizabeth as Co-Founder of the immunotherapy company SapVax, LLC. As an academic Professor navigating the difficult landscape of drug development, Elizabeth’s advice was invaluable as she helped us carve out a clear roadmap to generate and execute a preclinical drug development plan.  She provided an essential conduit to translate our academic discovery into commercial development in a highly professional and consultative manner. She was a pleasure to work with and she would be my “go to” person to help a new biotech start-up.

Elizabeth was part of the Allinaire Therapeutics team from the launch of the company in early 2016 until mid-2018.  She played a critical role in building a drug development program around discoveries made by myself and my Allinaire co-founder.  Elizabeth excels at seeing the big picture, while at the same time crafting a detailed plan for getting from point A to point B.  This trait enabled her to keep our team focused on major development milestones and business objectives while also managing day-to-day operations of the company.

Elizabeth wore many hats at Allinaire; she was intimately involved in planning and monitoring scientific studies, but also played a key role in other aspects of the company, such as managing the intellectual property, interfacing with investors, and contract negotiation.  In more than one instance, she was able to navigate complex contractual issues involving multiple parties in order to allow critical studies to be done.  Her unique ability to work across functional areas makes her a great asset to biotech start-ups.

dR. iRINA PETRACHE, md

CO-FOUNDER OF ALLINAIRE THERAPEUTICS, LLC

PROFESSOR OF MEDICINE & CHIEF OF PULMONARY, CRITICAL CARE AND SLEEP MEDICINE AT NATIONAL JEWISH HEALTH, DENVER, CO